Company Filing History:
2 out of 134 
1 out of 633 
1 out of 1,504 
Years Active: 2022-2025
Title: Lakshminarayanan Rajamani: Innovator in Antibiotic Development
Introduction
Lakshminarayanan Rajamani is a prominent inventor based in Singapore, known for his contributions to the field of antibiotic research. He holds 2 patents that focus on innovative approaches to combat antibiotic resistance.
Latest Patents
His latest patents include the molecular design of new antibiotics and antibiotic adjuvants against MCR strains. This invention relates to a compound comprising a hydrophobic moiety, a linker, and an N-containing moiety. The invention also details the method of synthesizing the compound and its use as an antibiotic or an adjuvant for an antibiotic. Another significant patent involves antimicrobial peptides comprising epsilon lysine residues. This disclosure relates to a peptide with at least five amino acid residues, where at least one is modified to an epsilon-lysine, delta-ornithine, gamma-2,4-diaminobutyric acid, or beta-2,3-diaminopropionic acid. The modified peptides display antimicrobial activity while exhibiting reduced or no cytotoxicity compared to non-modified peptides.
Career Highlights
Lakshminarayanan has worked with notable organizations such as Singapore Health Services Pte Ltd and Nanyang Technological University. His work in these institutions has significantly contributed to advancements in medical research and antibiotic development.
Collaborations
He has collaborated with esteemed colleagues, including Venkatesh Mayandi and Tze Leng Eunice Goh, to further his research and innovations in the field.
Conclusion
Lakshminarayanan Rajamani's work in antibiotic development showcases his commitment to addressing critical health challenges. His innovative patents and collaborations highlight his significant impact on the field of medical research.